Japan's Conditional/Time-Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets.

Hakariya H, Ozaki A, Kaneda Y, Tanimoto T

Open source

DOI
10.1002/cpt.3562
Published
2025 May
Container
Clinical pharmacology and therapeutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cpt.3562,
  title = {Japan's Conditional/Time-Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets.},
  author = {Hakariya H and Ozaki A and Kaneda Y and Tanimoto T},
  year = {2025},
  journal = {Clinical pharmacology and therapeutics},
  doi = {10.1002/cpt.3562},
  url = {https://doi.org/10.1002/cpt.3562}
}

RIS

TY  - JOUR
TI  - Japan's Conditional/Time-Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets.
AU  - Hakariya H
AU  - Ozaki A
AU  - Kaneda Y
AU  - Tanimoto T
PY  - 2025
JO  - Clinical pharmacology and therapeutics
DO  - 10.1002/cpt.3562
UR  - https://doi.org/10.1002/cpt.3562
ER  - 

APA

H, H., A, O., Y, K., & T, T. (2025). Japan's Conditional/Time-Limited Early Approval System in Regenerative Medicine: A Case Study of Rise and Falls of Autologous Skeletal Myoblast Sheets.. Clinical pharmacology and therapeutics. https://doi.org/10.1002/cpt.3562

Source records